Metodieva, G and Adoki, S and Lausen, B and Metodiev, MV (2016) 'Decreased Usage of Specific Scrib Exons Defines a More Malignant Phenotype of Breast Cancer With Worsened Survival.' EBioMedicine, 8. 150 - 158. ISSN 2352-3964

Preview	Text PIIS235239641630192X.pdf - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview
	Slideshow 10.1016-j.ebiom.2016.05.009Figure.ppt - Supplemental Material Download (465kB)

Abstract

© 2016 The Authors. SCRIB is a polarity regulator known to be abnormally expressed in cancer at the protein level. Here we report that, in breast cancer, an additional and hidden dimension of deregulations exists: an unexpected SCRIB exon usage pattern appears to mark a more malignant tumor phenotype and significantly correlates with survival. Conserved exons encoding the leucine-rich repeats tend to be overexpressed while others are underused. Mechanistic studies revealed that the underused exons encode part of the protein necessary for interaction with Vimentin and Numa1, a protein which is required for proper positioning of the mitotic spindle. Thus, the inclusion/exclusion of specific SCRIB exons is a mechanistic hallmark of breast cancer, which could potentially be exploited to develop more efficient diagnostics and therapies.

Item Type:	Article
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions:	Faculty of Science and Health > Life Sciences, School of Faculty of Science and Health > Mathematical Sciences, Department of
Depositing User:	Jim Jamieson
Date Deposited:	24 May 2016 14:51
Last Modified:	04 Sep 2019 01:15
URI:	http://repository.essex.ac.uk/id/eprint/16643

Actions (login required)

View Item